Shire PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shire PLC with three other
pharmaceutical manufacturers in Europe:
Lonza Group AG
sales of 4.13 billion Swiss Francs [US$4.09 billion]
H. Lundbeck A/S
(15.63 billion Danish Kroner [US$2.22 billion]
of which 19%
was Other Pharmaceuticals), and
Novo Nordisk As
based in Denmark
(111.78 billion Danish Kroner [US$15.85 billion]
of which 80%
was Diabetes Care).
During the year ended December of 2016, sales at
Shire PLC were £8.48 billion (US$10.57 billion).
increase of 101.4%
versus 2015, when the company's sales were £4.21 billion.
This was the fifth consecutive year of sales increases at Shire PLC
(and since 2011, sales have increased a total of 220%).